Literature DB >> 26374113

Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

I M Carvalho1, P B Coelho2, P C Costa1, C S Marques1, R S Oliveira2, D C Ferreira3.   

Abstract

The adult central nervous system is commonly known to have a very limited regenerative capacity. The presence of functional stem cells in the brain can therefore be seen as a paradox, since in other organs these are known to counterbalance cell loss derived from pathological conditions. This fact has therefore raised the possibility to stimulate neural stem cell differentiation and proliferation or survival by either stem cell replacement therapy or direct administration of neurotrophic factors or other proneurogenic molecules, which in turn has also originated regenerative medicine for the treatment of otherwise incurable neurodegenerative and neuropsychiatric disorders that take a huge toll on society. This may be facilitated by the fact that many of these disorders converge on similar pathophysiological pathways: excitotoxicity, oxidative stress, neuroinflammation, mitochondrial failure, excessive intracellular calcium and apoptosis. This review will therefore focus on the most promising achievements in promoting neuroprotection and neuroregeneration reported to date.

Entities:  

Keywords:  Curcuminoids; Neural stem cells; Neurodegenerative disorders; Neurogenesis; Neurotrophic factors; Retinoic acid

Mesh:

Substances:

Year:  2015        PMID: 26374113     DOI: 10.1007/s12017-015-8369-3

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  261 in total

Review 1.  Adult neurogenesis: a compensatory mechanism for neuronal damage.

Authors:  H G Kuhn; T D Palmer; E Fuchs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001-08       Impact factor: 5.270

2.  Targeting novel integrative nuclear FGFR1 signaling by nanoparticle-mediated gene transfer stimulates neurogenesis in the adult brain.

Authors:  Ewa K Stachowiak; Indrajit Roy; Yu-Wei Lee; Mariolina Capacchietti; John M Aletta; Paras N Prasad; Michal K Stachowiak
Journal:  Integr Biol (Camb)       Date:  2009-05-08       Impact factor: 2.192

3.  Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders.

Authors:  Bryan Jepson; Doreen Granpeesheh; Jonathan Tarbox; Melissa L Olive; Carol Stott; Scott Braud; J Helen Yoo; Andrew Wakefield; Michael S Allen
Journal:  J Autism Dev Disord       Date:  2011-05

4.  Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.

Authors:  Zahra Mansouri; Masoumeh Sabetkasaei; Fatemeh Moradi; Fatemeh Masoudnia; Amin Ataie
Journal:  J Mol Neurosci       Date:  2012-03-15       Impact factor: 3.444

5.  Distinct effect of neurotrophins delivered simultaneously by an adenoviral vector on neurite outgrowth of neural precursor cells from different regions of the brain.

Authors:  Minjoo Yoo; Insil Joung; Ah Mi Han; Hye Hyun Yoon; Yunhee Kim Kwon
Journal:  J Microbiol Biotechnol       Date:  2007-12       Impact factor: 2.351

Review 6.  Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity.

Authors:  D Suri; V A Vaidya
Journal:  Neuroscience       Date:  2012-09-09       Impact factor: 3.590

7.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

Review 8.  Adult neurogenesis and the memories of drug addiction.

Authors:  Juan J Canales
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-08       Impact factor: 5.760

9.  Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Authors:  Daniel A Rossignol; Lanier W Rossignol; Scott Smith; Cindy Schneider; Sally Logerquist; Anju Usman; Jim Neubrander; Eric M Madren; Gregg Hintz; Barry Grushkin; Elizabeth A Mumper
Journal:  BMC Pediatr       Date:  2009-03-13       Impact factor: 2.125

10.  Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease.

Authors:  Jackalina M Van Kampen; David Baranowski; Denis G Kay
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more
  4 in total

1.  Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study.

Authors:  Alok K Sharma; Nandini Gokulchandran; Pooja P Kulkarni; Hemangi M Sane; Ridhima Sharma; Alitta Jose; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2020-12-25

Review 2.  Bile Acids in Neurodegenerative Disorders.

Authors:  Hayley D Ackerman; Glenn S Gerhard
Journal:  Front Aging Neurosci       Date:  2016-11-22       Impact factor: 5.750

Review 3.  Harnessing migraines for neural regeneration.

Authors:  Jonathan M Borkum
Journal:  Neural Regen Res       Date:  2018-04       Impact factor: 5.135

4.  CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients.

Authors:  Anna Gójska-Grymajło; Maciej Zieliński; Dariusz Gąsecki; Kamil Kowalczyk; Mariusz Kwarciany; Barbara Seroczyńska; Walenty M Nyka
Journal:  Neuromolecular Med       Date:  2018-05-09       Impact factor: 3.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.